Search clinical trials for: fractionated rituximab
Total 2539 results
-
University Hospital, GenevaActive, not recruitingAggressive B-Cell Non-Hodgkin LymphomaSwitzerland
-
The Christie NHS Foundation TrustBayerCompletedFollicular LymphomaUnited Kingdom, France
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedRefractory Chronic Lymphocytic LeukemiaUnited States
-
Narendranath EpperlaEli Lilly and CompanyNot yet recruitingMarginal Zone LymphomaUnited States
-
Novartis PharmaceuticalsNot yet recruitingAnti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
-
Incyte CorporationRecruiting
-
National Cancer Institute (NCI)Not yet recruitingLeukemia, Lymphocytic, Chronic, B-Cell | B-Cell Chronic Lymphocytic Leukemia | B-Lymphocytic Leukemia, ChronicUnited States
-
Anhui Provincial HospitalNot yet recruitingHigh Titers of Anti-HLA Antibody (MFI ≥5000)China
-
AbbVieRecruiting
-
InnoCare Pharma Inc.Not yet recruitingMantle Cell Lymphoma
-
CelgeneNot yet recruitingLarge B-cell LymphomaUnited States, Canada, Argentina, Australia, Austria, Brazil, Bulgaria, Chile, China, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, Japan, Korea, Republic of, Malaysia, Mexico, New Zealand, Norway, Poland, Portug... and more
-
H. Lee Moffitt Cancer Center and Research InstituteBeiGene, Ltd.RecruitingFollicular Lymphoma | Marginal Zone Lymphoma | B-Cell LymphomaUnited States
-
Fondation Ophtalmologique Adolphe de RothschildNot yet recruiting
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
-
ImmunityBio, Inc.Not yet recruitingNon-Hodgkin Lymphoma Refractory/ Relapsed
-
National University Hospital, SingaporeRecruiting
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingRetroperitoneal SarcomaUnited States
-
Ascentage Pharma Group Inc.Recruiting
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationNot yet recruitingRelapsed or Refractory Follicular Lymphoma
-
Tianjin Medical University Cancer Institute and...Not yet recruitingAdvanced Hepatocellular CarcinomaChina
-
The Lymphoma Academic Research OrganisationGrupo Español de Linfomas y Transplante Autólogo de Médula Ósea; Swiss Group... and other collaboratorsNot yet recruitingFollicular LymphomaFrance, Belgium, Germany, Portugal, Spain
-
Artiva Biotherapeutics, Inc.RecruitingLupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingMantle Cell LymphomaUnited States
-
Institute of Hematology & Blood Diseases Hospital...RecruitingPlatelet Transfusion Refractoriness | Severe Aplastic AnemiaChina
-
Guangzhou Lupeng Pharmaceutical Company LTD.RecruitingB-cell Non-Hodgkin LymphomaChina
-
Beijing Friendship HospitalRecruitingMild Cognitive Impairment | Idiopathic Membranous NephropathyChina
-
Regeneron PharmaceuticalsRecruitingB-Cell Non-Hodgkin Lymphoma (B-NHL)Taiwan, Spain, Korea, Republic of, Thailand, Italy, Malaysia, Turkey, Australia
-
Stichting Hemato-Oncologie voor Volwassenen NederlandUMC Utrecht; Amsterdam University Medical Centers; The Dutch Network for Cardiovascular...Not yet recruitingDLBCL - Diffuse Large B Cell LymphomaNetherlands
-
Nathan DenlingerBristol-Myers SquibbRecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | Diffuse Large B-Cell Lymphoma-Recurrent | Follicular Lymphoma-Recurrent | High Grade B-Cell Lymphoma-Recurrent | Primary Mediastinal Large B-Cell Lymphoma-Recurrent | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent and other conditionsUnited States
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityRecruitingPrimary Ocular Adnexal MALT LymphomaChina
-
AbbVieGenmabRecruiting
-
University of Illinois at ChicagoRecruitingSuicideUnited States
-
National Research Center for Hematology, RussiaRecruitingPrimary Mediastinal LymphomaRussian Federation
-
French Innovative Leukemia OrganisationHoffmann-La RocheRecruiting
-
Yan Zhang, MDPeking University First Hospital; Chinese PLA General Hospital; Peking University...Recruiting
-
Mabscale, LLCRecruiting
-
BeBetter Med IncRecruitingRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
Henry Ford Health SystemRecruiting
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Italy, Poland, United States, Thailand, United Kingdom, Belgium, Turkey, Czechia
-
Lixia ShengNot yet recruitingOR Regimen Refractory Marginal Zone Lymphoma
-
Ruijin HospitalRecruiting
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
University of the PunjabNot yet recruiting
-
Regeneron PharmaceuticalsRecruitingFollicular Lymphoma (FL)Spain, United States, Turkey, Thailand, Belgium, Poland, Chile, Italy
-
Bristol-Myers SquibbRecruitingRelapsed/Refractory Non-Hodgkin LymphomaUnited States, Spain, France, Netherlands, Switzerland
-
Regeneron PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma (DLBCL)United States, Spain, Korea, Republic of, Belgium, Austria, Thailand, Singapore, Italy, France, Australia, Turkey, Poland, Czechia, Chile, United Kingdom, Germany
-
Regeneron PharmaceuticalsRecruitingFollicular Lymphoma (FL)Taiwan, Spain, Israel, United States, Switzerland, Poland, Austria, Turkey, United Kingdom, Czechia, Australia, Italy, Chile
-
Zhejiang Cancer HospitalRecruitingDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina